What's breaking now, across thousands of outlets.
Endeavor BioMedicines said its treatment for a chronic lung disease succeeded in a mid-stage test, claiming the drug had the potential to reverse the course of idiopathic pulmonary fibrosis in a ...
We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.
The season usually starts in October or November. But some western states, including California, Washington, Alaska and Hawaii, began seeing a rise in flu cases as early as August
The struggling cell therapy developer is exploring strategic alternatives, which, among other characteristics, make it a likely candidate to receive reverse merger interest.
(MedPage Today) -- The association between maternal influenza infection during pregnancy and neuropsychiatric disorders in children didn't hold up in sibling comparisons, according to a…
Plus news about ADC Therapeutics, Atrium Therapeutics, Bristol Myers, Novartis and Pfizer. Biohaven partners with Ono: Tokyo-based Ono Pharmaceutical has agreed to pay Biohaven $80 million upfront to…
[Capital FM] Nairobi -- East Africa has four years to deliver on its 2030 malaria elimination ambition, but lessons from China's seven-decade journey suggest the region must move faster from broad…
[Capital FM] Nairobi -- East Africa has four years to deliver on its 2030 malaria elimination ambition, but lessons from China's seven-decade journey suggest the region must move faster from broad…
